French researchers are planning to test nicotine patches on coronavirus patients and frontline health workers after a study suggested smokers may be much less at risk of contracting the virus.
The study at a major Paris hospital suggests a substance in tobacco – possibly nicotine – may be stopping patients who smoke from catching Covid-19. Clinical trials of nicotine patches are awaiting the approval of the country’s health authorities.
However, the researchers insisted they were not encouraging the population to take up smoking, which carries other potentially fatal health risks and kills 50% of those who take it up. While nicotine may protect those from the virus, smokers who have caught it often develop more serious symptoms because of the toxic effect of tobacco smoke on the lungs, they say.
Greece among the safest holiday destinations, German Bild reports
The team at Pitié-Salpêtrière hospital questioned 480 patients who tested positive for the virus, 350 of whom were hospitalised while the rest with less serious symptoms were allowed home.
It found that of those admitted to hospital, whose median age was 65, only 4.4% were regular smokers. Among those released home, with a median age of 44, 5.3% smoked.
Read more: The Guardian
